Lilly’s Mounjaro, based on the molecule tirzepatide, has enjoyed a first-mover advantage in India. The drug targets both GIP and GLP-1 receptors and has demonstrated weight loss of up to 23 per cent ...

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.